136 related articles for article (PubMed ID: 25042726)
21. gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen.
Côté HC; Lord ST; Pratt KP
Blood; 1998 Oct; 92(7):2195-212. PubMed ID: 9746756
[No Abstract] [Full Text] [Related]
22. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
Neerman-Arbez M; de Moerloose P; Honsberger A; Parlier G; Arnuti B; Biron C; Borg JY; Eber S; Meili E; Peter-Salonen K; Ripoll L; Vervel C; d'Oiron R; Staeger P; Antonarakis SE; Morris MA
Hum Genet; 2001 Mar; 108(3):237-40. PubMed ID: 11354637
[TBL] [Abstract][Full Text] [Related]
23. Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).
Dear A; Brennan SO; Dempfle CE; Kirschstein W; George PM
Thromb Haemost; 2004 Dec; 92(6):1291-5. PubMed ID: 15583736
[TBL] [Abstract][Full Text] [Related]
24. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
Spena S; Asselta R; Platé M; Castaman G; Duga S; Tenchini ML
Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317
[TBL] [Abstract][Full Text] [Related]
25. siRNA down-regulation of FGA mRNA in HepG2 cells demonstrated that heterozygous abnormality of the Aα-chain gene does not affect the plasma fibrinogen level.
Takezawa Y; Matsuda K; Terasawa F; Sugano M; Honda T; Okumura N
Thromb Res; 2013 Apr; 131(4):342-8. PubMed ID: 23414568
[TBL] [Abstract][Full Text] [Related]
26. Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia.
Tirefort Y; Alson OR; de Moerloose P; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):556-8. PubMed ID: 22732251
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage.
Callea F; Giovannoni I; Sari S; Guldal E; Dalgic B; Akyol G; Sogo T; Al-Hussaini A; Maggiore G; Bartuli A; Boldrini R; Francalanci P; Bellacchio E
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244742
[TBL] [Abstract][Full Text] [Related]
28. Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
Brennan SO; Chitlur M
Thromb Haemost; 2013 Jun; 109(6):1180-2. PubMed ID: 23467727
[No Abstract] [Full Text] [Related]
29. [Congenital afibrinogenemia associated with a novel nonsense mutation in the FGA gene].
Wu SY; Wang ZY; Dong NZ; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):133-6. PubMed ID: 15946522
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation in the fibrinogen γ-chain 216 Gly>Glu causes hypofibrinogenemia.
Marchi R; Brennan S; Mijares ME
Thromb Res; 2016 Nov; 147():61-62. PubMed ID: 27676255
[No Abstract] [Full Text] [Related]
31. A novel mutation in the FGG gene causes hypofibrinogenemia in a Chinese family.
Xie X; Du J; Geng S; Yi B; Li Q; Zuo J
Hereditas; 2024 Feb; 161(1):9. PubMed ID: 38374144
[TBL] [Abstract][Full Text] [Related]
32. Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
Neerman-Arbez M; Germanos-Haddad M; Tzanidakis K; Vu D; Deutsch S; David A; Morris MA; de Moerloose P
Blood; 2004 Dec; 104(12):3618-23. PubMed ID: 15284111
[TBL] [Abstract][Full Text] [Related]
33. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
35. Exon skipping and aberrant signal peptide cleavage produce novel fibrinogen with an Aα chain lacking the first 42 residues.
Brennan SO; Laurie AD; McRae S
Thromb Haemost; 2016 Aug; 116(3):581-5. PubMed ID: 27277572
[No Abstract] [Full Text] [Related]
36. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
37. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen Gdansk: hypofibrinogenemia associated with a novel missense mutation in FGA (Ser112Pro).
Mital A; Undas A; Neerman-Arbez M; Hellmann A
Thromb Res; 2012 Sep; 130(3):e196-7. PubMed ID: 22795623
[No Abstract] [Full Text] [Related]
39. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
[TBL] [Abstract][Full Text] [Related]
40. Congenital fibrinogen disorders: an update.
de Moerloose P; Casini A; Neerman-Arbez M
Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
